Form 4 for GILD Gilead Sciences
Accepted 2024-03-12 00:00:00 ET · period of report 2024-03-10 · accession 0001127602-24-009708 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-12 | 2024-03-10 | GILD | Patterson Sandra | SVP, Controllership | M - OptEx | — | +2,682 | 33.4K | +9% | — |
| D | 2024-03-12 | 2024-03-10 | GILD | Patterson Sandra | SVP, Controllership | F - Tax | $75.12 | -790 | 32.6K | -2% | -$59.3K |
| DM | 2024-03-12 | 2024-03-10 | GILD | Patterson Sandra | SVP, Controllership | M - OptEx | — | -2,682 | 15.8K | -15% | — |
| DM | 2024-03-12 | 2024-03-10 | GILD | Patterson Sandra | SVP, Controllership | A - Grant | $0.00 | +18.5K | 18.7K | +10,385% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-10 | M | A | 748 | — | 31,488 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2024-03-10 | M | A | 1,934 | — | 33,422 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 3 | Common | Common Stock | 2024-03-10 | F | D | 790 | $75.12 | 32,632 | D | — | — | |
| 4 | Derivative | Restricted Stock Unit | 2024-03-10 | M | D | 1,934 | — | 13,838 | D | — · — to — | 1,934 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F4) The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| 5 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-03-10 | A | A | 13,660 | $0.00 | 13,660 | D | $75.12 · — to 2034-03-10 | 13,660 Common Stock | (F5) The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| 6 | Derivative | Restricted Stock Unit | 2024-03-10 | A | A | 4,825 | — | 18,663 | D | — · — to — | 4,825 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F4) The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| 7 | Derivative | Restricted Stock Unit | 2024-03-10 | M | D | 748 | — | 15,772 | D | — · — to — | 748 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F3) The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested. |